Companies / BridgeBio Pharma, Inc. / Activity
Activity — BridgeBio Pharma, Inc.
90 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Apuli Maricel Executive | Sell | Common Stock | $132.0K | -2K -1.61% | 121,945 0.06% of shares | medium |
| Jan 9, 2026 | Kumar Neil CEO | Sell | Common Stock | $105.9K | -1K -0.03% | 4,537,046 2.32% of shares | medium |
| May 15, 2026 | Scott Randal W. Director | Sell | Common Stock | $103.2K | -2K -11.37% | 11,789 <0.01% of shares | medium |
| Jun 20, 2026 | Homcy Charles J Director | Other | Common Stock | $52.2K | -788 -0.09% | 915,886 0.47% of shares | low |
| Feb 19, 2026 | Kumar Neil CEO | Sell | Common Stock | $43.8K | -602 -0.26% | 234,451 0.12% of shares | low |
| Feb 17, 2026 | Apuli Maricel Executive | Sell | Common Stock | $37.9K | -510 -0.41% | 123,945 0.06% of shares | low |
| Jan 8, 2026 | Kumar Neil CEO | Sell | Common Stock | $30.1K | -400 -0.05% | 735,686 0.38% of shares | low |
| Jan 9, 2026 | Kumar Neil CEO | Sell | Common Stock | $29.3K | -375 -0.05% | 715,686 0.37% of shares | low |
| Jan 8, 2026 | Kumar Neil CEO | Sell | Common Stock | $22.6K | -300 -0.01% | 4,538,447 2.32% of shares | low |
| Mar 12, 2026 | Kumar Neil CEO | Sell | Common Stock | $21.0K | -300 -0.01% | 4,458,447 2.28% of shares | low |
| Mar 12, 2026 | Kumar Neil CEO | Sell | Common Stock | $21.0K | -300 -0.05% | 655,686 0.34% of shares | low |
| Feb 17, 2026 | Trimarchi Thomas Executive | Sell | Common Stock | $15.1K | -200 -0.06% | 336,585 0.17% of shares | low |
| May 15, 2026 | Scott Randal W. Director | Sell | Common Stock | $13.8K | -200 -1.70% | 11,589 <0.01% of shares | low |
| Jun 22, 2026 | Aguiar Eric Director | Grant | Common Stock | $0 | +4K +60.56% | 10,579 <0.01% of shares | low |
| Jun 22, 2026 | McCormick Frank Director | Grant | Common Stock | $0 | +4K +60.56% | 10,579 <0.01% of shares | low |
| Jun 22, 2026 | Momtazee James C Director | Grant | Common Stock | $0 | +4K +26.46% | 19,070 <0.01% of shares | low |
| Jun 22, 2026 | Homcy Charles J Director | Grant | Common Stock | $0 | +4K +0.44% | 919,876 0.47% of shares | low |
| Jun 22, 2026 | Daniels Ronald J Director | Grant | Common Stock | $0 | +4K +23.48% | 20,981 0.01% of shares | low |
| Jun 22, 2026 | Hassan Fred Director | Grant | Common Stock | $0 | +4K +15.41% | 29,879 0.02% of shares | low |
| Mar 18, 2026 | Trimarchi Thomas Executive | Grant | Common Stock | $0 | +59K +17.54% | 395,626 0.20% of shares | low |
| Mar 18, 2026 | Apuli Maricel Executive | Grant | Common Stock | $0 | +14K +11.62% | 136,115 0.07% of shares | low |
| May 15, 2026 | Scott Randal W. Director | Exercise | Stock Option (Right to Buy) | — | -10K -31.75% | 21,501 0.01% of shares | low |
| Jun 22, 2026 | Aguiar Eric Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | McCormick Frank Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Momtazee James C Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Homcy Charles J Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Daniels Ronald J Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Hassan Fred Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Mar 17, 2026 | Kumar Neil CEO | Grant | Restricted Stock Units | — | +104K | 104,313 0.05% of shares | low |
| Mar 17, 2026 | Kumar Neil CEO | Grant | Stock Option (Right to Buy) | — | +41K | 40,570 0.02% of shares | low |
| Mar 10, 2026 | Valantine Hannah Director | Exercise | Stock Option (Right to Buy) | — | -9K -33.33% | 17,343 <0.01% of shares | low |
| Mar 4, 2026 | Ellis Andrea Director | Exercise | Stock Option (right to buy) | — | -65K -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Valantine Hannah Director | Exercise | Stock Option (Right to Buy) | — | -25K -100.00% | 0 0.00% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Restricted Stock Units | — | -12K -7.69% | 138,645 0.07% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Restricted Stock Units | — | -20K -11.11% | 156,794 0.08% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Restricted Stock Units | — | -34K -20.00% | 134,176 0.07% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Common Stock | — | +12K +4.10% | 293,474 0.15% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Common Stock | — | +20K +7.47% | 281,920 0.14% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Common Stock | — | +34K +14.66% | 262,320 0.13% of shares | low |
| Feb 17, 2026 | Scott Randal W. Director | Exercise | Stock Option (Right to Buy) | — | -10K -24.10% | 31,501 0.02% of shares | low |